Crush The Market

undefined Logo

Teva Pharmaceutical Industries Limited

8.67 USD

+0.70%

Add To Watchlist

Page 1 of 20

2021-2002

Currency in USD2021
PeriodFY
Revenue15.88 Billion
Cost Of Revenue8.28 Billion
Gross Profit7.59 Billion
Gross Profit Ratio0.48
Research And Development Expenses967.00 Million
General And Administrative Expenses1.10 Billion
Selling And Marketing Expenses2.43 Billion
Selling General And Administrative Expenses3.53 Billion
Other Expenses0.00
Operating Expenses4.50 Billion
Cost And Expenses12.78 Billion
Interest Income0.00
Interest Expense891.00 Million
Depreciation And Amortization1.33 Billion
Ebitda2.85 Billion
Ebitdaratio0.18
Operating Income1.72 Billion
Operating Income Ratio0.11
Total Other Income Expenses Net-1.06 Billion
Income Before Tax658.00 Million
Income Before Tax Ratio0.04
Income Tax Expense211.00 Million
Net Income417.00 Million
Net Income Ratio0.03
Eps0.38
Epsdiluted0.38
Weighted Average Shs Out1.10 Billion
Weighted Average Shs Out Dil1.11 Billion
Linkhttps://www.sec.gov/Archives/edgar/data/818686/000119312522032667/0001193125-22-032667-index.htm
Final Linkhttps://www.sec.gov/Archives/edgar/data/818686/000119312522032667/d130792d10k.htm

Crush The Market

We Use Cookies